Claudio Cappelli

<scp>TRPM</scp>4 regulates Akt/<scp>GSK</scp>3‐β activity and enhances β‐catenin signaling and cell proliferation in prostate cancer cells

Alfredo Sagredo, Eduardo A. Sagredo, Claudio Cappelli et al. · Molecular Oncology · 2017 · 82 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Intraglomerular Monocyte/Macrophage Infiltration and Macrophage–Myofibroblast Transition during Diabetic Nephropathy Is Regulated by the A2B Adenosine Receptor

Ángelo Torres, Katherin Muñoz, Yéssica Nahuelpán et al. · Cells · 2020 · 52 citations · Full text

Medicine, Pathology, Pharmacology +17

Blockade of the Adenosine A3 Receptor Attenuates Caspase 1 Activation in Renal Tubule Epithelial Cells and Decreases Interleukins IL-1β and IL-18 in Diabetic Rats

Wallys Garrido, Claudia Jara, Ángelo Torres et al. · International Journal of Molecular Sciences · 2019 · 27 citations · Full text

Medicine, Pathobiology, Pharmacology +17

The TGF-β profibrotic cascade targets ecto-5′-nucleotidase gene in proximal tubule epithelial cells and is a traceable marker of progressive diabetic kidney disease

Claudio Cappelli, Analia Tellez, Claudia Jara et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2020 · 20 citations

Life Sciences, Cell Biology, Molecular Biology +13

BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model

Esteban Quezada, Claudio Cappelli, Iván Darío Parrado Díaz et al. · Clinical Epigenetics · 2021 · 17 citations · Full text

Life Sciences, Neurology, Neuroscience +17